PHC Holdings Corporation

Equities

6523

JP3801300009

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
1,122 ^JPY	-0.18%		+1.81%	-21.92%

Apr. 22	Plant Health Care's Fertilizer Receives Belgian Approval	MT
Apr. 04	Plant Health Care Wins Regulatory Approval to Launch New Biological Product in Mexico	MT

Bio-Techne Corporation reached an agreement to acquire Lunaphore Technologies SA from PHC Holdings Corporation and others for approximately $170 million.

June 21, 2023

Bio-Techne Corporation (NasdaqGS:TECH) reached an agreement to acquire Lunaphore Technologies SA from PHC Holdings Corporation (TSE:6523) and others for approximately $170 million on June 22, 2023. Bio-Techne acquired Lunaphore for approximately $165 million, net of cash acquired. The transaction is expected to complete in first quarter of fiscal year 2024.

Wenger Plattner acted as legal advisor to Bio-Techne. Bourgeois Avocat SA acted as legal advisor and UBS Investment Bank acted as financial advisor to Lunaphore Technologies.

Latest news about PHC Holdings Corporation

Plant Health Care's Fertilizer Receives Belgian Approval	Apr. 22	MT
Plant Health Care Wins Regulatory Approval to Launch New Biological Product in Mexico	Apr. 04	MT
Plant Health Care Secures Approval for Fungicide Peptide Product in Mexico	Feb. 22	MT
PHC Holdings Co., Ltd. Announces Management Changes	Feb. 12	CI
PHC Holdings Co., Ltd. Announces Chief Executive Officer Changes	Feb. 12	CI
Transcript : PHC Holdings Corporation, Q3 2024 Earnings Call, Feb 09, 2024	Feb. 09
Plant Health Care Wins Approval for Peptide Product in Brazil	Jan. 02	MT
Transcript : PHC Holdings Corporation, Q2 2024 Earnings Call, Nov 10, 2023	Nov. 10
Tailam Tech Construction Logs 10.5% Drop in H1 Profit	23-08-18	MT
Plant Health Care Obtains Brazilian Nod for Fungicide	23-08-18	MT
Pathway Health Corp Annoucnes Resignation of Management Team and Board	23-07-28	MT
Bio-Techne Corporation completed the acquisition of Lunaphore Technologies SA from PHC Holdings Corporation and others for approximately $170 million.	23-07-06	CI
Plant Health Care plc Raises GBP3 Million in Fundraising Round	23-06-23	MT
Plant Health Care Seeks Nearly GBP3 Million from Share Sale	23-06-23	MT
Bio-Techne Corporation reached an agreement to acquire Lunaphore Technologies SA from PHC Holdings Corporation and others for approximately $170 million.	23-06-21	CI
PHC Holdings Corporation acquired remaining 30% stake in Scimed Pte Ltd.	23-06-14	CI
Plant Health Care Secures Distribution Deal for Wilbur-Ellis' Foliar Fungicide in US	23-06-14	MT
PHC Holdings Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-10	CI
Plant Health Care's Novel Bionematicide Technology Receives First-stage Approval for Commercial Use in Brazil	23-05-09	MT
Higher Eurozone Inflation, Declining Factory Activity Weigh on EU Stocks, Closing Lower Tuesday	23-05-02	MT
Plant Health Care to Review London AIM Listing; Shares Plunge 20%	23-05-02	MT
Major incident after fluid leak at southern England harbour - BBC	23-03-26	RE
Lunaphore Technologies SA announced that it has received CHF 40 million in funding from EGS Beteiligungen AG, PHC Holdings Corporation, Swiss Entrepreneurs Foundation, Occident Group AG, Redalpine Venture Partners AG, Norgine Ventures Management Limited	23-03-22	CI
Transcript : PHC Holdings Corporation, Senseonics Holdings, Inc. - Shareholder/Analyst Call	23-03-15
Senseonics Holdings, Inc. announced that it has received $14.962978 million in funding from PHC Holdings Corporation	23-03-12	CI

Chart PHC Holdings Corporation

Duration

Period

More charts

Company Profile

PHC Holdings Corp is a Japan-based company mainly engaged in the development, manufacture and sale of healthcare devices and services. The Company operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-09 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for PHC Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

1,122 JPY

Average target price

1,200 JPY

Spread / Average Target

+6.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PHC HOLDINGS CORPORATION	-21.92%	898M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution